MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
OMGA Omega Therapeutics
- 0.837
- +0.025+3.02%
Close Dec 20 16:00 ET
- 0.837
- +0.000+0.01%
Post 20:01 ET
46.34MMarket Cap-0.63P/E (TTM)
0.880High0.792Low180.79KVolume0.800Open0.812Pre Close151.06KTurnover0.84%Turnover RatioLossP/E (Static)55.37MShares6.30052wk High4.02P/B18.03MFloat Cap0.75052wk Low--Dividend TTM21.54MShs Float31.410Historical High--Div YieldTTM10.78%Amplitude0.750Historical Low0.835Avg Price1Lot Size
About Omega Therapeutics Company
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
Company Profile
SymbolOMGA
Company NameOmega Therapeutics
Listing DateJul 30, 2021
Issue Price17.00
Founded2016
CEOMr. Mahesh Karande
MarketNASDAQ
Employees94
Fiscal Year Ends12-31
Address140 First Street,Suite 501
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-949-4360
Company Executives
- Name
- Position
- Salary
- Dr. Kaan Certel, PhD
- Director, President and Chief Executive Officer
- --
- Ling Zeng, J.D.
- Chief Legal and Administrative Officer
- --
- Dr. Thomas McCauley, PhD
- Chief Scientific Officer
- --
- Barbara Y. Chan
- Principal Financial Officer and Principal Accounting Officer
- --
- Christian Stanton Schade
- Chairman of the Board
- 135.55K
- Ravi Mehrotra, PhD
- Director
- --
- Robert L. Rosiello
- Director
- --
- Richard N. Kender, M.B.A.
- Independent Director
- --
- Michelle C. Werner
- Independent Director
- 97.51K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 149.19K
- Mary T. Szela
- Independent Director
- 153.68K
- Rainer J. Boehm, M.B.A.
- Independent Director
- 148.68K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.